Published online Mar 6, 2025. doi: 10.12998/wjcc.v13.i7.98000
Revised: October 22, 2024
Accepted: November 14, 2024
Published online: March 6, 2025
Processing time: 163 Days and 17.9 Hours
Core Tip: Childhood cancer and contemporary anticancer therapies responsible for excellent cure rates can produce adverse, long-term, health-related outcomes, referred to as late effects. Therapy-related long-term complications may affect multiple organs and organ systems, including cardiovascular, endocrine/metabolic, reproductive, neurologic, immune, pulmonary, gastrointestinal, urinary, musculoskeletal, auditory, ocular, dermatologic and oral/dental organs, as well as contribute to the risk of neurocognitive and psychosocial difficulties, and subsequent malignant neoplasms. Many of these late effects are life-altering or potentially life-threatening. Long-term multidisciplinary follow-up of childhood cancer survivors is recommended for the prevention, early detection, and treatment of late effects.
